TCL Archive NCI Proposes Extension Of Breast Cancer Screening To Determine Efficacy Of Biennial Tests November 7, 1975
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award July 10, 1987
